The following Corporate guidance note provides comprehensive and up to date legal information covering:
The operation of the UK takeovers regime may be affected by Brexit. For further details of its impact, see Practice Note: Brexit—UK takeover regime. For the purposes of this note, the principal change relates to the companies to which DTR 5 applies. For further details, see: Disclosure Guidance and Transparency Rules—DTR 5 below.
The disclosure of shareholdings and dealings prior to and during a takeover offer is the subject of substantial and overlapping statute and regulation. The Panel on Takeovers and Mergers (Panel) describes such disclosure as necessary to uphold the General Principle under the Takeover Code (Code) that all parties to an offer must avoid the creation of false markets in the securities of an offeror or offeree.
In practice, the requirement to disclose interests and dealings during a takeover bid primarily seeks to deter the practice of stakebuilding, whereby a person accumulates and warehouses, without public disclosure, a significant shareholding in another company. Building a substantial stake in an offeree in this manner may deprive:
the offeree board of appropriate opportunities to prepare a defence or manage their relationship with a new major shareholder
offeree shareholders of the opportunity to receive an appropriate bid premium on the sale of their shares on a change of control
market participants of relevant
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234